|
|
[ILMU MUDAH]: Apa pendapat anda tentang Vaccine untuk Covid-19?
[Copy link]
|
|
|
ipes2 replied at 6-6-2021 10:39 PM
hi hi makan comfort food nanti gomoks!
Maintain. Baju longgar2...mujo sempat beli baju raya ri tu...
Parents kolig dah kena angkut ambulan hari ni kat NS...sedih dia x jumpa...doakan ye...huhu...
. |
|
|
|
|
|
|
|
|
|
|
|
Bod sinun...
Laporan polis terhadap DG KKM Selain telah difailkan semakan kehakiman,difahamkan beberapa laporan polis dibuat ke atas Dr Hisham.
Laporan polis disokong 200 doktor mendakwa adalah 1 jenayah kemanusiaan apabila tolak cadangan penggunaan Ivermectin sebagai ubat penyembuh Covid- Abodul Rani Kulup Fans Twitter
JUST IN!
Tahu atau tidak kenapa nada Dr. Hitler Hisham berubah pasal Ivermectin malam tadi dengan mengatakan dalam ujian klinikal?
Selain telah difailkan semakan kehakiman, aku difahamkan beberapa laporan polis dibuat ke atas Dr. Hitler Hisham.
Laporan polis disokong 200 doktor mendakwa adalah satu jenayah kemanusiaan apabila tolak cadangan penggunaan Ivermectin.
Dulu dalam 4 orang sahaja doktor, now we have 200 medical doctors with us.
Yes, we have a numbers!!
Pinjam ayat Anwar Ibrahim kejap.
Nota kaki: patutlah tak tidur malam tadi update FB pasal Ivermectin- FB Yuseri Yusoff
|
|
|
|
|
|
|
|
|
|
|
|
alhamdulillah MIL adik keypo dah ok
harap FIL pon ok jugak insyaAllah, ameen
|
|
|
|
|
|
|
|
|
|
|
|
South African variant found in 23 Kelantan cases
A total of 23 Covid-19 cases involving the South African variant have been detected in Kelantan so far, said state health director Dr Zaini Hussin.
All cases recorded involved Malaysians, and the latest involved the Padang Tembak cluster and Kampung Bunut Susu, Bernama reported.
He said the public should remain at home if there are no important matters to attend to, and follow health and hygiene protocols.
Kelantan recorded a total of 270 new Covid-19 cases bringing the cumulative total to 30,142 while there are 7,596 active cases.
He said new infections in Kelantan were on the decrease. |
|
|
|
|
|
|
|
|
|
|
|
MIL nya Alhamdulillah dah sihat.. FIL nya dah meninggal Khamis lepas.. after 28 days in the hospital..
|
|
|
|
|
|
|
|
|
|
|
|
keypochino replied at 7-6-2021 04:06 PM
MIL nya Alhamdulillah dah sihat.. FIL nya dah meninggal Khamis lepas.. after 28 days in the hospit ...
Yeah told us, sedih jugak dapat tau..al fatihah untuk arwah.. |
|
|
|
|
|
|
|
|
|
|
|
Thank you.. harap family adik ipar tabah.. especially the mom.. take care tau..
|
|
|
|
|
|
|
|
|
|
|
|
Tq Dr @ipes2,
Will proceed with AZ without worries 
|
|
|
|
|
|
|
|
|
|
|
|
|
Setuju tak setuju.. pilihan or takde pilihan... apa pun kita anggap inilah salah satu usah kita.. kalau dah habis usah.. so kita bertawakkal lah dengan apa juga keadaan.. moga kita sentiasa dijauhkan dari segala fitnah akhir zaman.. |
|
|
|
|
|
|
|
|
|
|
|
Edited by seribulan at 8-6-2021 02:55 PM
[BACK TO #VACCINESWORK
Ivermectin: why a potential COVID treatment isn’t recommended for use
The antiparasitic drug was thought to be a potential treatment for COVID-19, but there isn't sufficient evidence to recommend its use, despite widespread support online. []22 April 2021 – by Gordon Dent
[siz
As the search continues for treatments for COVID-19, the results from a number of studies have led to changes in the advice on which drugs to give people who are suffering from the disease.
The European Medicines Agency and the United States National Institutes of Health have recently stated that one previously promising treatment – the antiparasitic drug, ivermectin – is not recommended for use in routine management of COVID-19 patients. Despite these decisions, support for ivermectin has been circulating on social media and in WhatsApp groups, with rumours abounding that the drug is being blocked on purpose. Some have dubbed it the “new hydroxycholoroquine”, after a treatment that received a significant amount of online support but was found in trials to be ineffective against COVID-19.
So what is ivermectin, and why have national agencies ruled against it?
WHAT IS IVERMECTIN?
Ivermectin was first developed in the 1970s from a bacterium in a soil sample collected from woods alongside a Japanese golf course (no other source has ever been found). In the intervening years, the effectiveness of ivermectin and its derivatives in treating parasitic worm infections transformed human and veterinary medicine, leading to a Nobel Prize for its discoverers, William C Campbell and Satoshi Ömura.
In humans, ivermectin is currently prescribed in tablet form to treat certain roundworm infections that cause illnesses such as river blindness. It may also be applied as a cream to control the common inflammatory skin condition papulopustular rosacea. But ivermectin is most commonly used for veterinary parasitic diseases, especially gastrointestinal worm infestations. Consequently, it is readily available and relatively inexpensive.
Have you read?
As ivermectin is more extensively used in veterinary than human medicine, however, the US Food and Drug Administration found it necessary to issue a warning in April 2020 against use of veterinary preparations in human patients with COVID-19.
WHY MIGHT IT BE USED TO TREAT COVID?
How did a drug mainly used to treat intestinal parasites in cows come to be of interest to doctors treating humans with COVID-19? In early 2020, a paper was made public (before it was reviewed by other scientists) which showed ivermectin suppresses the replication of the SARS-CoV-2 virus, which causes COVID-19, under laboratory conditions. This was one of many studies over the past 50 years to show that the antiparisitic drug could also have antiviral uses. There appear to be two key ways in which the drug could prevent coronavirus replication. First, it could prevent the virus from suppressing our cells’ natural antiviral responses. Second, it’s possible the drug prevents the “spike” protein on the surface of the virus from binding to the receptors that allow it to enter our cells. Along with the anti-inflammatory actions apparent from ivermectin’s efficacy in rosacea, these may point towards useful effects in a viral disease that causes significant inflammation. These initial findings were used as the basis of numerous recommendations for ivermectin’s use to treat COVID-19, particularly in Latin America, which were later retracted.
WHY IS IT CONTROVERSIAL?
Since then, there have been numerous studies into ivermectin as a potential treatment for COVID-19. In late 2020, a research group in India was able to summarise the results of four small studies of ivermectin as an add-on treatment in COVID-19 patients. This review showed a statistically significant improvement in survival among patients who received ivermectin in addition to other treatments. But the authors stated clearly that the quality of the evidence was low and that the findings should be treated with caution. As is frequently the case for reviews of multiple small studies, the paper suggested that further trials were needed to determine whether ivermectin was indeed clinically effective.
A controversy subsequently blew up over an article by the Front Line COVID-19 Critical Care Alliance, a group of doctors and researchers that lobbies for the use of ivermectin. This article, summarising multiple small studies of the effects of ivermectin on COVID-19 patients, was provisionally accepted for publication in the journal Frontiers in Pharmacology in January 2021 but then rejected and removed from the journal’s website in March. The journal’s editor stated that the standard of evidence in the paper was insufficient and that the authors were inappropriately promoting their own ivermectin-based treatment.
One larger randomised clinical trial was published in March 2021. This showed no effect of ivermectin on duration of symptoms of adults with mild COVID-19. The authors stated that the findings did not support the use of ivermectin in these patients, but again highlighted that larger trials were needed to determine whether the drug had other benefits.
WHY ISN’T IT RECOMMENDED?
While some other studies did appear to show benefits of ivermectin, many did not. These were summarised by the National Institutes of Health, showing severe limitations arising from small sample sizes and problems with study design. Both the National Institutes of Health and the European Medicines Agency judged, on the basis of these studies, that there is currently insufficient evidence to support the use of ivermectin in treatment of COVID-19.
More studies are underway. A large, multicentre trial began in February to determine the effectiveness of ivermectin as well as metformin (an anti-diabetes medication) and fluvoxamine (an antidepressant) in preventing COVID-19 disease progression. It would therefore be premature to conclude absolutely that ivermectin has no place in COVID-19 treatment. On the basis of current evidence, however, its use cannot be recommended.
|
Rate
-
1
View Rating Log
-
|
|
|
|
|
|
|
|
|
|
|
do proceed; dan keep a look out for any possible side effects. the great majority of people, hnyalah local pain dan some mild to moderate fever, kdg2 with muscle aches.. membuktikan pada kita badan kita tgh membuat pelbagai usaha utk ''bertindak melawan'' antigen dari vaccine tadi.. sekaligus memberi kita immunity kepada kandungan vaccine tadi. plenty of water, dan active2 selalu
|
|
|
|
|
|
|
|
|
|
|
|
I
Edited by seribulan at 9-6-2021 02:50 PM
Indian Bar Association sues WHO scientist over Ivermectin- by Justus R. Hope, MD
- Jun 7, 2021 Updated Jun 7, 2021
- 0
[backcolor=rgba(0, 0, 0, 0.9)]
The Indian Bar Association (IBA) sued WHO Chief Scientist Dr. Soumya Swaminathan on May 25, accusing her in a 71-point brief of causing the deaths of Indian citizens by misleading them about Ivermectin. Point 56 states, “That your misleading tweet on May 10, 2021, against the use of Ivermectin had the effect of the State of Tamil Nadu withdrawing Ivermectin from the protocol on May 11, 2021, just a day after the Tamil Nadu government had indicated the same for the treatment of COVID-19 patients.”
https://science.thewire.in/health/tn-revises-protocols-leaves-out-Ivermectin-for-covid-patients/
Advocate Dipali Ojha, lead attorney for the Indian Bar Association, threatened criminal prosecution against Dr. Swaminathan “for each death” caused by her acts of commission and omission. The brief accused Swaminathan of misconduct by using her position as a health authority to further the agenda of special interests to maintain an EUA for the lucrative vaccine industry. https://indianbarassociation.in/press-releases/
Specific charges included the running of a disinformation campaign against Ivermectin and issuing statements in social and mainstream media to wrongfully influence the public against the use of Ivermectin despite the existence of large amounts of clinical data showing its profound effectiveness in both prevention and treatment of COVID-19. In particular, the Indian Bar brief referenced the peer-reviewed publications and evidence compiled by the ten-member Front Line COVID-19 Critical Care Alliance (FLCCC) group and the 65-member British Ivermectin Recommendation Development (BIRD) panel headed by WHO consultant and meta-analysis expert Dr. Tess Lawrie. The brief cited US Attorney Ralph C. Lorigo’s hospital cases in New York where court orders were required for dying COVID patients to receive the Ivermectin. In multiple instances of such comatose patients, following the court-ordered Ivermectin, the patients recovered. In addition, the Indian Bar Association cited previous articles published in this forum, The Desert Review. Advocate Ojha accused the WHO and Dr. Swaminathan in Points 60 and 61 as having misled and misguided the Indian people throughout the pandemic from mask wear to exonerating China as to the virus's origins.
“The world is gradually waking up to your absurd, arbitrary and fallacious approach in presenting concocted facts as ‘scientific approach.’ While the WHO flaunts itself like a ‘know it all,’ it is akin to the vain Emperor in new clothes while the entire world has realized by now, the Emperor has no clothes at all.” The brief accused the WHO of being complicit in a vast disinformation campaign. Point 61 states, “The FLCCC and the BIRD have shown exemplary courage in building a formidable force to tackle the challenge of disinformation, resistance, and rebuke from pharma lobbies and powerful health interests like WHO, NIH, CDC, and regulators like the US FDA.” Dr. Swaminathan was called out for her malfeasance in discrediting Ivermectin to preserve the EUA for the vaccine and pharmaceutical industry. Point 52 reads, “It seems you have deliberately opted for deaths of people to achieve your ulterior goals, and this is sufficient grounds for criminal prosecution against you.”
The Indian Bar Association posted an update on their website June 5, 2021, noting that Dr. Swaminathan had deleted her now-infamous tweet. They wrote, "However, deleting the tweet will not save Dr. Soumya Swaminathan and her associates from the criminal prosecution which is to be launched by the citizens with active support from the Indian Bar Association."
https://indianbarassociation.in/blogs-iba/
In this update, Advocate Dipali Ojha clarified the nature of the planned action, "The Indian Bar Association has warned action under section 302 etc. of the Indian Penal Code against Dr. Soumya Swaminathan and others, for murder of each person dying due to obstruction in treatment of COVID-19 patient effectively by Ivermectin. Punishment under section 302 of the Indian Penal Code is death penalty or life imprisonment." He further wrote, "After receiving the said notice, Dr. Soumya Swaminathan went on the back foot and deleted her tweet. This has proved the hollowness of the WHO’s recommendation against Ivermectin for COVID-19. The dishonesty of WHO and the act of Dr. Soumya Swaminathan in deleting her contentious tweet was witnessed by citizens across the world, as the news got a wide coverage on social media. By deleting the tweet, Dr. Soumya Swaminathan has proved her mala fide intentions." The entire world witnessed the effectiveness of Ivermectin against India’s deadly second surge as the locations that adopted it saw their outbreaks quickly extinguished in stark contrast to those states that did not. Among the most prominent examples include the Ivermectin areas of Delhi, Uttar Pradesh, Uttarakhand, and Goa where cases dropped 98%, 97%, 94%, and 86%, respectively. By contrast, Tamil Nadu opted out of Ivermectin. As a result, their cases skyrocketed and rose to the highest in India. Tamil Nadu deaths increased ten-fold.
https://www.thedesertreview.com/news/national/ivermectin-obliterates-97-percent-of-delhi-cases/article_6a3be6b2-c31f-11eb-836d-2722d2325a08.html Tamil Nadu publicly relied upon Dr. Swaminathan's advice in revoking their initial choice of Ivermectin the day after she recommended against it in her May 10 tweet on social media. As a direct result, Tamil Nadu experienced a surge in COVID death and sickness that continues to this day. The Indian Bar Association dared to initiate a landmark court case against a Public Health Authority (PHA) to call out corruption and to save lives. As the courts in the United States proved to be the life-saving force to ensure a patient’s right to receive Ivermectin, a court in India is now doing the same. Criminal prosecution of public health officials will send a powerful signal that disinformation campaigns resulting in death carry consequences. Perhaps this pathway will ultimately break the disinformation and censorship stranglehold around repurposed drug use to save lives. Maybe we will witness other countries following India’s example, both in medicine and in law. Signed, Justus R. Hope, MD
|
|
|
|
|
|
|
|
|
|
|
|
KKM lulus cadangan warga perubatan terlibat program vaksinasi
Diterbitkan 9 Jun 2021, 5:16 pm
Kementerian Kesihatan Malaysia (KKM) meluluskan cadangan untuk memanggil warga perubatan seperti pesara, graduan, doktor dan jururawat sukarelawan serta swasta untuk melibatkan diri dalam program vaksinasi Covid-19 sebagai usaha mencapai sasaran kadar vaksinasi tinggi negara.
Menterinya Datuk Seri Dr Adham Baba berkata golongan itu akan menyumbang kepada peningkatan jumlah tenaga di pusat vaksinasi dan berperanan sebagai pemvaksin serta menguruskan kes di pusat pemerhatian.
Dalam sidang media perkembangan Program Imunisasi Covid-19 Kebangsaan bersama Menteri Penyelaras Program Imunisasi Covid-19 Kebangsaan Khairy Jamaluddin di Putrajaya hari ini, beliau berkata langkah itu membantu Malaysia mencapai kapasiti 200,000 dos vaksin sehari menjelang bulan depan.
"Langkah yang mendapat kelulusan ialah semua houseman (doktor pelatih) yang ada di hospital kita dan dalam posting keenam, mereka akan kita gerakkan ke pusat vaksin sebagai pemberi suntikan vaksin dan menguruskan kes di pusat pemerhatian.
"Kedua, mereka yang merupakan graduan dari sekolah perubatan seperti doktor, doktor gigi, MA (pembantu perubatan) atau jururawat, kita mula gerakkan mereka untuk diberikan latihan dan lesen amalan bagi mengendalikan pusat vaksin.
"Ketiga, mereka yang pencen dan tamat perkhidmatan awal juga, kita panggil supaya beri tumpuan pada program ini," katanya.
Selain itu, beliau berkata KKM turut menjemput doktor sukarelawan yang bekerja sambilan di hospital swasta menyertai program itu dan diberikan kredit bagi sijil amalan tahunan mereka.
- Bernama
|
|
|
|
|
|
|
|
|
|
|
|
This post contains more resources
You have to Login for download or view attachment(s). No Account? Register
x
|
|
|
|
|
|
|
|
|
|
|
PETALING JAYA: Seorang doktor mengesahkan klinik swastanya diserbu Kementerian Kesihatan semalam kerana membekalkan ubat antiparasit, Ivermectin kepada orang awam bagi mencegah jangkitan Covid-19.
Pada 16 Mei lalu, Ketua Pengarah Kesihatan, Dr Noor Hisham Abdullah dilaporkan berkata, KKM belum meluluskan penggunaan ubat Ivermectin untuk mencegah atau merawat Covid-19 kerana tiada kajian saintifik untuk membuktikan keberkesanannya.
Dr Amir Farid Isahak mengesahkan kliniknya di Kuala Lumpur diserbu pihak berkuasa, namun enggan mengulas lanjut atas nasihat peguamnya.
“Kenyataan itu memang saya buat, tetapi peguam saya sudah nasihatkan supaya tidak buat sebarang kenyataan ketika ini,” katanya kepada FMT. Dalam kenyataan semalam, beliau menjelaskan kadar vaksinasi terlalu perlahan menyebabkan beliau selaku doktor kesihatan awam membuat keputusan untuk menggunakan ubat berkenaan kerana ia terbukti selamat.
“Saya terima 58 kajian saintifik yang dijalankan setakat ini menunjukkan keberkesanannya mengurangkan jangkitan dan kesan yang teruk akibat Covid-19.
“Oleh itu, saya bertindak menurut apa yang saya percaya, dan berusaha menyelamatkan nyawa,” katanya yang sedar keputusannya itu salah dan akan sampai ke pengetahuan KKM.
Bagaimanapun, beliau berkata menyelamatkan nyawa manusia adalah keutamaan ketika ini berbanding takut kepada tindakan undang-undang. “Saya sedia untuk berdepan akibatnya,” katanya.
FMT sedang mendapatkan respons Noor Hisham mengenai perkara berkenaan.
Awal Jun lalu, KKM bersama Institut Penyelidikan Klinikal (ICR) memulakan ujian klinikal bagi mengkaji kesan serta keberkesanan penggunaan Ivermectin untuk merawat pesakit Covid-19 yang berisiko tinggi di 12 hospital kerajaan.
Noor Hisham dilaporkan berkata, Ivermectin adalah sejenis ubat antiparasit yang diluluskan Pentadbiran Makanan dan Ubat-ubatan Amerika Syarikat (FDA serta digunakan secara meluas bagi merawat beberapa penyakit tropika terabai, termasuk onchocerciasis, strongyloidiasis dan helminthiases, namun belum ada bukti konklusif untuk mengesyorkan penggunaan Ivermectin bagi merawat Covid-19.
Penggunaan “off-label” Ivermectin meraih perhatian masyarakat antarabangsa susulan beberapa kajian kes dan ujian klinikal menunjukkan keputusan yang baik dalam merawat Covid-19.
Bagaimanapun, FDA tidak meluluskan penggunaan Ivermectin bagi merawat dan mencegah Covid-19 pada manusia dan Pertubuhan Kesihatan Sedunia (WHO) hanya mengesyorkan penggunaannya dalam ujian klinikal, dengan pesakit perlu dipantau doktor pakar dan penyelidik berpengalaman untuk menjamin keselamatan serta keberkesanannya.
|
|
|
|
|
|
|
|
|
|
|
|
|
Doc @ipes2 knp klu anaphylatic tak tau eja btl ke tak (allergic sampai block nafas) tak boleh divaksin |
|
|
|
|
|
|
|
|
|
|
|
Jumlah pemberian vaksin COVID-19 setakat 17 Jun 2021 ialah 5,330,654 dos.
221,706 dos pada 17 Jun.
Jumlah yang terima dos pertama ialah 3,810,071 orang. Daripada jumlah itu, 1,520,583 orang juga terima dos kedua
Daftar di MySejahtera, vaksincovid.gov.my Tel 1800888828
|
|
|
|
|
|
|
|
|
|
|
|
This post contains more resources
You have to Login for download or view attachment(s). No Account? Register
x
|
|
|
|
|
|
|
|
|
|
|
jika org itu ada anaphylactic reaction kepada sesuatu, maka kita tak mau lah dia di-expose kepada element itu.
contoh mudah, ada org ada bad allergic reaction kepada telur sampai membawa kepada anaphylaxis, maka oleh kerana some componenet vaccines ada guna elements dari telor, maka dia tak boleh lah di vaccinate dgn vaccine tadi. jika vaccine tadi tidak guna component itu, maka ok lah utk di vaccinate.
|
|
|
|
|
|
|
|
|
|
|
|
4,000 wanita UK alami perubahan kitaran haid selepas vaksin
Oleh Media Mulia
22 Jun 2021, 3:59 pm
LONDON: Hampir 4,000 wanita melaporkan mereka mengalami perubahan kitaran haid selepas menerima suntikan vaksin Covid-19 di United Kingdom (UK).
Pakar Obstetrik dan Ginekologi Royal College (RCOG) menyatakan terdapat wanita yang mengalami perubaharan kitaran haid dalam jangka hayat mereka dan perkara itu mungkin berlaku ketika mendapatkan suntikan vaksin.
Data vaksinasi juga tidak menunjukkan masalah berhubung kitaran haid wanita selepas menerima suntikan vaksin.
Namun, RCOG mengesahkan ada sejumlah wanita mengalami pendarahan haid yang lebih banyak selepas terima vaksin dan pakar giat meneliti faktor kemungkinan ia berlaku.
Sebanyak 2,734 wanita membuat laporan mengenai masalah kitaran haid mereka selepas menerima vaksin AstraZeneca, 1,158 (Pfizer) dan 66 (Moderna) sehingga 17 Mei lalu.
Kebanyakannya membuat laporan mengenai mengalami pendarahan haid yang lebih banyak.
Sehubungan itu, timbalan presiden keahlian RCOG, Dr, Pat O’Brien menegaskan bahawa kesan sampingan vaksin adalah ringan dan perkara itu tidak sepatutnya menjadi halangan untuk golongan wanita mendapatkan vaksin.
“Banyak wanita akan mengalami prubahan kitaran haid sepanjang hayat mereka dan itu adalah perkara biasa,” katanya.
Sehingga kini, UK sudah memberikan suntikan vaksin sebanyak 43,127,763 dos pertama dan 31,449,915 lengkap dos kedua.
|
|
|
|
|
|
|
|
|
|
| |
|
Post time 7-6-2021 12:29 AM
Author
Post time 8-6-2021 11:57 AM
